Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Similar articles for PubMed (Select 21917638)


Jejunal linoleic acid infusions require GLP-1 receptor signaling to inhibit food intake: implications for the effectiveness of Roux-en-Y gastric bypass.

Dailey MJ, Moghadam AA, Moran TH.

Am J Physiol Endocrinol Metab. 2011 Dec;301(6):E1184-90. doi: 10.1152/ajpendo.00335.2011. Epub 2011 Sep 13.


Nutrient specific feeding and endocrine effects of jejunal infusions.

Dailey MJ, Tamashiro KL, Terrillion CE, Moran TH.

Obesity (Silver Spring). 2010 May;18(5):904-10. doi: 10.1038/oby.2010.14. Epub 2010 Feb 4.


Exogenous peptide YY3-36 and Exendin-4 further decrease food intake, whereas octreotide increases food intake in rats after Roux-en-Y gastric bypass.

Fenske WK, Bueter M, Miras AD, Ghatei MA, Bloom SR, le Roux CW.

Int J Obes (Lond). 2012 Mar;36(3):379-84. doi: 10.1038/ijo.2011.126. Epub 2011 Jun 21.


Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats.

Chelikani PK, Haver AC, Reidelberger RD.

Am J Physiol Regul Integr Comp Physiol. 2005 Jun;288(6):R1695-706. Epub 2005 Feb 17.


Truncal and hepatic vagotomy reduce suppression of feeding by jejunal lipid infusions.

Cox JE, Kelm GR, Meller ST, Spraggins DS, Randich A.

Physiol Behav. 2004 Mar;81(1):29-36.


Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose.

Burmeister MA, Ayala J, Drucker DJ, Ayala JE.

Am J Physiol Endocrinol Metab. 2013 Apr 1;304(7):E677-85. doi: 10.1152/ajpendo.00446.2012. Epub 2013 Jan 22.


Effects of exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats.

Reidelberger RD, Haver AC, Apenteng BA, Anders KL, Steenson SM.

Obesity (Silver Spring). 2011 Jan;19(1):121-7. doi: 10.1038/oby.2010.136. Epub 2010 Jun 17.


Acute peripheral GLP-1 receptor agonism or antagonism does not alter energy expenditure in rats after Roux-en-Y gastric bypass.

Abegg K, Schiesser M, Lutz TA, Bueter M.

Physiol Behav. 2013 Sep 10;121:70-8. doi: 10.1016/j.physbeh.2013.03.027. Epub 2013 Apr 3.


Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling.

Hayes MR, Bradley L, Grill HJ.

Endocrinology. 2009 Jun;150(6):2654-9. doi: 10.1210/en.2008-1479. Epub 2009 Mar 5.


Suppression of food intake by glucagon-like peptide-1 receptor agonists: relative potencies and role of dipeptidyl peptidase-4.

Jessen L, Aulinger BA, Hassel JL, Roy KJ, Smith EP, Greer TM, Woods SC, Seeley RJ, D'Alessio DA.

Endocrinology. 2012 Dec;153(12):5735-45. doi: 10.1210/en.2012-1358. Epub 2012 Oct 2.


Nutrient-specific feeding and endocrine effects of jejunal infusions in obese animals.

Dailey MJ, Moghadam AA, Moran TH.

Am J Physiol Regul Integr Comp Physiol. 2014 Mar 15;306(6):R420-8. doi: 10.1152/ajpregu.00410.2013. Epub 2014 Jan 22.


Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats.

Hayes MR, Kanoski SE, Alhadeff AL, Grill HJ.

Obesity (Silver Spring). 2011 Jul;19(7):1342-9. doi: 10.1038/oby.2011.50. Epub 2011 Mar 17.


Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass.

le Roux CW, Welbourn R, Werling M, Osborne A, Kokkinos A, Laurenius A, Lönroth H, Fändriks L, Ghatei MA, Bloom SR, Olbers T.

Ann Surg. 2007 Nov;246(5):780-5.


GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents.

Ye J, Hao Z, Mumphrey MB, Townsend RL, Patterson LM, Stylopoulos N, Münzberg H, Morrison CD, Drucker DJ, Berthoud HR.

Am J Physiol Regul Integr Comp Physiol. 2014 Mar 1;306(5):R352-62. doi: 10.1152/ajpregu.00491.2013. Epub 2014 Jan 15.


The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors.

Mietlicki-Baase EG, Ortinski PI, Rupprecht LE, Olivos DR, Alhadeff AL, Pierce RC, Hayes MR.

Am J Physiol Endocrinol Metab. 2013 Dec 1;305(11):E1367-74. doi: 10.1152/ajpendo.00413.2013. Epub 2013 Oct 8.


Suppression of food intake, body weight, and body fat by jejunal fatty acid infusions.

Cox JE, Tyler WJ, Randich A, Kelm GR, Bharaj SS, Jandacek RJ, Meller ST.

Am J Physiol Regul Integr Comp Physiol. 2000 Mar;278(3):R604-10.


The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide.

Kanoski SE, Rupprecht LE, Fortin SM, De Jonghe BC, Hayes MR.

Neuropharmacology. 2012 Apr;62(5-6):1916-27. doi: 10.1016/j.neuropharm.2011.12.022. Epub 2011 Dec 28.


Intestinal fatty acid infusion modulates food preference as well as calorie intake via the vagal nerve and midbrain-hypothalamic neural pathways in rats.

Ogawa N, Ito M, Yamaguchi H, Shiuchi T, Okamoto S, Wakitani K, Minokoshi Y, Nakazato M.

Metabolism. 2012 Sep;61(9):1312-20. doi: 10.1016/j.metabol.2012.02.011. Epub 2012 Mar 24.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk